Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: Alkenylacyl subclasses are preferred targets

Clinical Biochemistry

Volumn 29, Issue 5, 1996, Pages 445-450

  Hofer, Gerald ^b   Lichtenberg, Dov ^b   Kostner, Gert M ^b   Hermetter, Albin ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b NONE

Author keywords

atherosclero sis; diphenylhexatriene; high density lipoprotein; lipoprotein(a); low density lipoprotein; phosphatidylcholine; plasmalogen; sphingomyelin

Indexed keywords

GLYCEROPHOSPHOLIPID; HIGH DENSITY LIPOPROTEIN; PLASMALOGEN; SPHINGOLIPID;

ARTICLE; ATHEROGENESIS; LIPID OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0040289304     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-9120(96)00061-6     Document Type: Article

References (30)

1. 1. Steinberg D, Parthasarathy S, Carew TE, Kooh JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
2. 2. Sommer A, Prenner E, Gorges R, et al. Organisation of phosphatidylcholine and sphingomyelin in the surface monolayer of low density lipoprotein and lipoprotein (a) as determined by time-resolved fluorometry. J Biol Chem 1992; 267: 24217-24222.
3. 3. Myher JJ, Kuksis A, Shepherd J, et al. Effect of saturated and unsaturated fat diets on molecular species of phosphatidylcholine and sphingomyelin of human plasma lipoproteins. Biochim Biophys Acta 1981; 666: 110-119.
4. 4. Hofer G, Lichtenberg D, Hermetter A. A new fluorescence method for the continuous determination of surface lipid oxidation in lipoproteins and plasma. Free Rad Res Comm 1995; 23: 317-327.
5. 5. Kalb E, Paltauf F, Hermetter A. Fluorescence lifetime distributions of diphenylhexatriene-labeled phosphatidylcholine as a tool for the study of phospholipid-cholesterol interactions. Biophys J 1989; 56: 1245-1253.
6. 6. Loidl J, Schwabe G, Paschke E, Paltauf F, Hermetter A. Uptake of fluorescent plasmalogen analogs by cultured human skin fibroblasts deficient in plasmalogen. Biochim Biophys Acta 1990; 1049: 75-84.
7. 7. Steyrer E, Kostner GM. The interaction of Lipoprotein Lp(a) with the B/E-receptor. J Lipid Res 1990; 31: 1247-1253.
8. 8. Kostner GM. Isolation, subfractionation, and characterization of human serum high-density lipoproteins. In: Day CE, Ed. High-density lipoproteins. Pp. 1-42. Marcel Dekker, New York:, 1981.
9. 9. Armstrong VW, Walli AK, Seidl D. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 1985; 26: 1314-1323.
10. 10. Gaubatz JW, Heideman C, Gotto Jr. AM, Morrisett JD, Dahlen GH. Human plasma lipoprotein (a). Structural properties. J Biol Chem 1983; 258: 4582-4589.
11. 11. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52.
12. 12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951; 193: 265-275.
13. 13. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957; 226: 497-509.
14. 14. Broekhuyse RM. Phospholipids in tissue of the eye. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids. Biochim Biophys Acta 1968; 152: 307-315.
15. 15. Sattler W, Kostner GM, Waeg G, Esterbauer H. Oxidation of Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta 1991; 1081: 65-74.
16. 16. Chapman MJ. Comparative analysis of mammalian plasma lipoproteins. In: Segrest JP, Albers JJ, Eds. Methods in enzymology. VoI 128. Pp. 70-144. London: Academic Press, 1986.
17. 17. Gorges R, Hofer G, Sommer A, et al. Transfer of phospholipase A-resistant pyrene-dialky-glycerophosphocholine to plasma lipoproteins: differences between Lp(a) and LDL. J Lipid Res 1995; 36: 251-259.
18. 18. Esterbauer H, Jürgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin Lipidol 1993; 4: 114-124.
19. 19. Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992; 89: 10316-10320.
20. 20. Engelmann B, Bräutigam C, Thiery J. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem Biophys Res Commun 1994; 204: 1235-1242.
21. 21. Jürgens G, Fell A, Ledinski G, Chen Q, Paltauf F. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogen. Chem Phys Lipids 1995; 77: 25-31.
22. 22. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986; 6: 505-510.
23. 23. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-190.
24. 24. Blencowe C, Hermetter A, Kostner GM, Deigner HP. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein. J Biol Chem 1995; 270: 31151-31157.
25. 25. Steinbrecher UP, Pritchard PH. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 1989; 30: 305-315.
26. 26. Scanu AM, Fless GM. Lipoprotein(a): Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-1715.
27. 27. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a): A risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 398-401.
28. 28. Morand OH, Zoeller A, Raetz CRH. Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation. J Biol Chem 1988; 263: 11597-11606.
29. 29. Sommer A, Paltauf F, Hermetter A. Dipolar solvent relaxation on a nanosecond time scale in ether phospholipid membranes as determined by multifrequency phase and modulation fluorometry. Biochemistry 1990; 29: 11134-11140.
30. 30. Szolderits G, Daum G, Paltauf F, Hermetter A. Protein-catalyzed transport of ether phospholipids. Biochim Biophys Acta 1991; 1063: 197-202.